Jaguar Health Inc

Jaguar Health insider buying shows confidence amid volatility, offering insights on plant‑derived therapeutics, FDA prospects, and value‑based reimbursement.

Jaguar Health insider buying surge after a 25‑for‑1 reverse split signals leadership confidence amid a volatile biotech market, but investors weigh regulatory, reimbursement, and capital risks.